Brief: Medesis Pharma Wins Brazil Approval For Phase II Nanomanganese® Test

Medesis Pharma SA

22/11/2021 08:12

Nov 22 (Reuters) - Medesis Pharma SA  ALMDP.PA :
    * TREATMENT OF SEVERE FORMS OF COVID-19 : PHASE II CLINICAL
TRIAL
AUTHORISED BY THE HEALTH AUTHORITIES IN BRAZIL
    * APPROVAL TO CONDUCT A PHASE II CLINICAL TRIAL OF ITS
NANOMANGANESE® PROGRAMME
    * WINS BRAZIL APPROVAL FOR ITS PHASE II TESTS FOR ITS
NANOMANGANESE TEST FOR SERIOUS FORMS OF COVID-19
    * THE RESULTS OF THIS STUDY ARE EXPECTED BEFORE THE SUMMER
OF
2022, SUBJECT TO THE EVOLUTION OF THE EPIDEMIC IN BRAZIL

Source text for Eikon:  ID: 
Further company coverage:  ALMDP.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))